Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection.
Phase of Trial: Phase IV
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Retapamulin (Primary)
- Indications Eczema; Folliculitis; Impetigo; Methicillin-resistant Staphylococcus aureus infections; Soft tissue infections
- Focus Therapeutic Use
- 20 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 16 Feb 2012 Planned end date changed from 1 Apr 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
- 21 May 2010 New trial record